BOLT
Price
$5.44
Change
+$0.29 (+5.63%)
Updated
Aug 25, 03:40 PM (EDT)
Capitalization
10.45M
IDYA
Price
$24.70
Change
-$0.42 (-1.67%)
Updated
Aug 25, 04:59 PM (EDT)
Capitalization
2.2B
77 days until earnings call
Interact to see
Advertisement

BOLT vs IDYA

Header iconBOLT vs IDYA Comparison
Open Charts BOLT vs IDYABanner chart's image
Bolt Biotherapeutics
Price$5.44
Change+$0.29 (+5.63%)
Volume$133
Capitalization10.45M
IDEAYA Biosciences
Price$24.70
Change-$0.42 (-1.67%)
Volume$8.93K
Capitalization2.2B
BOLT vs IDYA Comparison Chart in %
Loading...
BOLT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IDYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BOLT vs. IDYA commentary
Aug 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BOLT is a Hold and IDYA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 26, 2025
Stock price -- (BOLT: $5.44 vs. IDYA: $24.71)
Brand notoriety: BOLT and IDYA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BOLT: 71% vs. IDYA: 73%
Market capitalization -- BOLT: $10.45M vs. IDYA: $2.2B
BOLT [@Biotechnology] is valued at $10.45M. IDYA’s [@Biotechnology] market capitalization is $2.2B. The market cap for tickers in the [@Biotechnology] industry ranges from $99.72B to $0. The average market capitalization across the [@Biotechnology] industry is $1.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BOLT’s FA Score shows that 1 FA rating(s) are green whileIDYA’s FA Score has 0 green FA rating(s).

  • BOLT’s FA Score: 1 green, 4 red.
  • IDYA’s FA Score: 0 green, 5 red.
According to our system of comparison, IDYA is a better buy in the long-term than BOLT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BOLT’s TA Score shows that 4 TA indicator(s) are bullish while IDYA’s TA Score has 5 bullish TA indicator(s).

  • BOLT’s TA Score: 4 bullish, 6 bearish.
  • IDYA’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, IDYA is a better buy in the short-term than BOLT.

Price Growth

BOLT (@Biotechnology) experienced а +7.37% price change this week, while IDYA (@Biotechnology) price change was -0.16% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.46%. For the same industry, the average monthly price growth was +23.43%, and the average quarterly price growth was +29.28%.

Reported Earning Dates

IDYA is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+1.46% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IDYA($2.2B) has a higher market cap than BOLT($10.4M). IDYA YTD gains are higher at: -3.852 vs. BOLT (-49.133). BOLT has higher annual earnings (EBITDA): -51.83M vs. IDYA (-380.2M). IDYA has more cash in the bank: 670M vs. BOLT (34.8M). BOLT has less debt than IDYA: BOLT (24.2M) vs IDYA (26.6M). IDYA has higher revenues than BOLT: IDYA (7M) vs BOLT (4.17M).
BOLTIDYABOLT / IDYA
Capitalization10.4M2.2B0%
EBITDA-51.83M-380.2M14%
Gain YTD-49.133-3.8521,275%
P/E RatioN/AN/A-
Revenue4.17M7M60%
Total Cash34.8M670M5%
Total Debt24.2M26.6M91%
FUNDAMENTALS RATINGS
IDYA: Fundamental Ratings
IDYA
OUTLOOK RATING
1..100
81
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
PROFIT vs RISK RATING
1..100
70
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
48
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BOLTIDYA
RSI
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 4 days ago
73%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
75%
Bearish Trend 4 days ago
84%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 4 days ago
77%
MACD
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 4 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 4 days ago
77%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 4 days ago
81%
Advances
ODDS (%)
Bullish Trend 1 day ago
72%
Bullish Trend 4 days ago
77%
Declines
ODDS (%)
Bearish Trend 8 days ago
90%
Bearish Trend 11 days ago
77%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 4 days ago
81%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 4 days ago
76%
View a ticker or compare two or three
Interact to see
Advertisement
BOLT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IDYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GIXIX10.63N/A
N/A
Nationwide International Index R6
TQCYX19.92N/A
N/A
Touchstone Dividend Equity Y
ERSMX32.51N/A
N/A
Eaton Vance Atlanta Capital SMID-Cap R
APPIX16.66N/A
N/A
Appleseed Institutional
DVRUX17.91N/A
N/A
UBS US Dividend Ruler P